Skip to content

Scientific Advisory Committee

Scientific Advisory Committee

OCRA’s Scientific Advisory Committee (SAC) comprises renowned doctors and researchers in the field of gynecologic oncology who help determine which grants we fund. This panel of esteemed experts reviews hundreds of proposals annually, selecting the most innovative and promising.

Meet the SAC

Former Members

  • Jeff Boyd, PhD
  • Carmel J. Cohen, MD
  • Alan D. D’Andrea, MD
  • Ronny I. Drapkin, MD, PhD
  • Annie Ellis
  • Ellen L. Goode, PhD
  • Susan Leighton
  • Ernst Lengyel, MD, PhD
  • Douglas A. Levine, MD
  • Joyce Liu, MD
  • Carolyn Muller, MD, FACOG
  • Kunle Odunsi, MD, PhD
  • Bob Ozols, MD, PhD
  • Daniel J. Powell Jr., PhD
  • Stephen C. Rubin, MD
  • Michael Seiden, MD, PhD
  • Elizabeth Swisher, MD

Related Topics

The Overview: August 2026

The Overview: August 2026

September is Ovarian and Gynecologic Cancer Awareness Month—a time for our community to unite, raise awareness, and push forward in the search for better treatments and cures. This year, that push forward took a major step. In May, we launched the Research Exchange, a new kind of online community that represents a fundamental shift in how … Continued

Read more

The FDA Wants to Hear From You at OCRA’s Online Conference

The FDA Wants to Hear From You at OCRA’s Online Conference

Submit Your Questions for the FDA Listening Session On September 16–17, Ovarian Cancer Research Alliance (OCRA) will host the International Gynecologic Cancer Conference®, the largest conference dedicated to the gynecologic cancer community. Day 2 features a special opportunity: a Listening Session with leaders from the U.S. Food and Drug Administration (FDA). Ask questions about the FDA’s … Continued

Read more

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

Our website uses cookies to ensure you get the best experience. By continuing to use this website, you indicate that you have read and agree to our Terms of Use and Privacy Policy.